Ray Blanco’s FDA Trader Review – Is it good?

Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains.

I subscribed to the Ray Blanco’s FDA Trader and bought four of the recommended stocks when the newsletter came out. In a period of less than 6 months I have had winners from all the picks – KYTH + 57%; IMGN + 58%, RVNC +63%; INCY +93%.

This is a pretty good track record. We are in a very bullish biotech market, and with a company’s outcome dependent on an external regulatory body (like the FDA) it may take time to get these results. All in all this has been outside of the Stansberry Research newsletters, the best for me.

What’s it Ray Blanco’s FDA Trader Newsletter?

Ray Blanco’s FDA Trader is the single best way to connect the dots that link today’s dynamic, innovative medical market to the outsized gains we see ahead for these specialized kinds of plays.

What kind of gains?

In 2013 alone, the drug stock Celldex was up 408%. Insys shot up 411%… Lannett rose 526%… and BioTelemetry went up 416%. These gains are more than achievable. Our four-part portfolio consists of plays that could go up 50–100% within a three-week to three-month holding period, along with more buy-and-hold strategies that we expect will pay out up to 500% gains over the course of three–five years.

Biotechnology and medical technology are never going to go away. There will always be a demand to fix the things that go wrong with our bodies. Diabetes was not something that anybody really cared about 30 or 40 years ago. Today, about a third of the U.S. will have diabetes in the near future. So in other words, there will always be a need for medical technology and medical innovation. There’s no biotechnology fund will use this tried-and-true four-part trading system.

Watch Technology Profits Confidential’s Apple-Fi 5G Killer Here

Who the heck is Ray Blanco?

Ray Blanco’s FDA Trader Review
Ray Blanco’s FDA Trader Review

His family fled Cuba in the 1960s. They settled in Florida, where Ray was born and spent his early childhood years…

Growing up, I’ll bet you knew a kid like Ray. As a child, getting smarter was his idea of fun.

When Ray was 10, he was the geek. He spent hours in his room every night typing programming code into his Timex Sinclair 1000.

By eighth grade, while most other kids were outside knocking a baseball around, Ray was in his basement figuring out how to build what’s called a “Wilson Cloud Chamber” — a supercooled device for detecting particles of ionizing radiation.

After earning a bachelor’s degree in information technology from Hodges University, Ray Blanco spent over a decade working for public and private companies as a network technician and systems analyst.

Ray used to work for one of the most successful private wealth management firms in the country — with over $30 billion in assets under management — designing and overseeing their entire network infrastructure, everything from internet connectivity to data integrity and security.

This experience included technology management for large trading and investment firms. From advanced robotics and avionics… to genomics and biotechnology… Ray is an expert.

Combining his passion for technology with his financial and stock market expertise, he joined Agora Financial in 2009.

He is the editor of Technology Profits Confidential, Ray Blanco’s FDA Trader, Penny Pot Profits and Breakthrough Technology Alert and contributes to Tomorrow’s Trends Today.

What you gonna get for your money with Ray Blanco’s FDA Trader Advisory?

As soon as you fill out the secure order form, your report The Announcement That’ll Change Medicine Forever: Your Chance To Amass Millions, containing all the details will be sent to you right away.

And I’ve arranged a deal to offer a full year of Ray Blanco’s FDA Trader for over 50% off…

Because the opportunity in front of us here today is just too important to miss out on.

Typically, the published price is $3,000. (A lot of your fellow readers have paid that price.)

However, today you’ll pay just $1,495 for a one-year membership.

As soon as you join, you’ll have a new email with your copy of The Announcement That’ll Change Medicine Forever: Your Chance To Amass Millions ready for immediate download.

Along with it, you’ll also receive another bonus report titled How to Spend Your First Million Dollars. I think it’ll come in handy in the coming weeks.

On top of that, over the next year, as a member of Ray Blanco’s FDA Trader

You’ll receive a new flash alert every time Ray Blanco identifis a new company with a medical breakthrough which includes his complete market analysis in addition to the recommendation.

Because, as you’ve seen today, getting in on the ground floor ahead of the announcement of a medical breakthrough…

Can be one of the easiest ways to amass a quick fortune.

1 thought on “Ray Blanco’s FDA Trader Review – Is it good?”

Leave a Comment